Skip to main content

Table 12 Metabolic follow-up, monitoring of diet and nutritional status, and long term complications

From: Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia

Assessment

Frequency

1. Metabolic follow-up

NH3, blood gases, lactate

Each clinic visit

Quantitative plasma amino acids (3-4 h fasting)

Every 3-6 months

MMA plasma and urine

Every 3-6 months

Free carnitine plasma (or dried blood spots)

Every 6-12 months

2. Monitoring of diet and nutritional status

Diet history

Each clinic visit

Growth (weight, length/height, BMI)

Each clinic visit

Clinical examination e.g. skin, hair

Each clinic visit

Albumin, pre-albumin

Every 6 months

Bone health (calcium, phosphorus, alkaline phosphatase, magnesium, parathyroid hormone, 25-OH vitamin D)

Annually, more frequently in case of chronic kidney disease

FBC, zinc, selenium, ferritin, folic acid, vitamin B12

Annually

3. Monitoring of long term complications

Neurological examination with detailed history of developmental milestones

Each clinic visit

Kidney function (glomerular and tubular function)* (serum creatinine, urea, electrolytes, cystatin C, uric acid, urinary electrolytes and protein loss, GFR)

Biochemistry, urine: every 6 mo* GFR*: annually, beginning at 6 y or earlier, if other renal function markers are abnormal

Pancreas (amylase &lipase)

Every 6 months

Heart (ECG, echocardiography)

Baseline âž” annually, start at 6 y

Formal developmental/IQ assessment

At defined ages

Ophthalmologic assessment

Annually after 6 y

EEG, MRI, formal hearing test

If clinical suspicion/indication

Dentist/oral care

Regularly

  1. *Monitoring of kidney function should be performed every 6 months in MMA; in PA annual monitoring is sufficient and GFR measurement is only indicated if other renal function markers are abnormal.
  2. Grade of recommendation: D.